miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy
Authors
Keywords
miR-22, Osteosarcoma, Proliferation, Migration, HMGB1
Journal
TUMOR BIOLOGY
Volume 35, Issue 7, Pages 7025-7034
Publisher
Springer Nature
Online
2014-04-22
DOI
10.1007/s13277-014-1965-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells
- (2014) Hua Zhu et al. Autophagy
- MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer
- (2013) C. Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- HMGB1 in Cancer: Good, Bad, or Both?
- (2013) R. Kang et al. CLINICAL CANCER RESEARCH
- The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)
- (2013) Haiyan Hu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Myc–microRNA network promotes exit from quiescence by suppressing the interferon response and cell-cycle arrest genes
- (2013) Damon Polioudakis et al. NUCLEIC ACIDS RESEARCH
- Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
- (2012) S. Jube et al. CANCER RESEARCH
- Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma
- (2012) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA signatures of resveratrol in the ischemic heart
- (2011) Partha Mukhopadhyay et al. Annals of the New York Academy of Sciences
- miRNA-34a is associated with docetaxel resistance in human breast cancer cells
- (2011) L. Kastl et al. BREAST CANCER RESEARCH AND TREATMENT
- HMGB1 Promotes Drug Resistance in Osteosarcoma
- (2011) J. Huang et al. CANCER RESEARCH
- High-Mobility Group Box 1 Is Essential for Mitochondrial Quality Control
- (2011) Daolin Tang et al. Cell Metabolism
- MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy
- (2011) Zhenyou Zou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease
- (2011) Patrick Brest et al. NATURE GENETICS
- High-Mobility Group Box 1, Oxidative Stress, and Disease
- (2010) Daolin Tang et al. ANTIOXIDANTS & REDOX SIGNALING
- High-mobility group box 1 and cancer
- (2010) Daolin Tang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Endogenous HMGB1 regulates autophagy
- (2010) Daolin Tang et al. JOURNAL OF CELL BIOLOGY
- HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells
- (2010) L Liu et al. LEUKEMIA
- A sensitive non-radioactive northern blot method to detect small RNAs
- (2010) Sang Woo Kim et al. NUCLEIC ACIDS RESEARCH
- HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
- (2010) D Tang et al. ONCOGENE
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The Double-Edged Sword of Autophagy Modulation in Cancer
- (2009) E. White et al. CLINICAL CANCER RESEARCH
- Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines
- (2009) Z. Duan et al. MOLECULAR CANCER THERAPEUTICS
- Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
- (2009) B Song et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started